Method Article

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

DOI:

10.3791/62387

October 20th, 2021

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Based on a hepatitis B virus (HBV)-derived peptide matrix, HBV-specific CD4 T-cell responses could be evaluated in parallel with identification of HBV-specific CD4 T-cell epitopes.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

CD4 T cells play important roles in the pathogenesis of chronic hepatitis B. As a versatile cell population, CD4 T cells have been classified as distinct functional subsets based on the cytokines they secreted: for example, IFN-γ for CD4 T helper 1 cells, IL-4 and IL-13 for CD4 T helper 2 cells, IL-21 for CD4 T follicular helper cells, and IL-17 for CD4 T helper 17 cells. Analysis of hepatitis B virus (HBV)-specific CD4 T cells based on cytokine secretion after HBV-derived peptides stimulation could provide information not only about the magnitude of HBV-specific CD4 T-cell response but also about the functional subsets of HBV-specific CD4 T cells. Novel approaches, such as transcriptomics and metabolomics analysis, could provide more detailed functional information about HBV-specific CD4 T cells. These approaches usually require isolation of viable HBV-specific CD4 T cells based on peptide-major histocompatibility complex-II multimers, while currently the information about HBV-specific CD4 T-cell epitopes is limited. Based on an HBV-derived peptide matrix, a method has been developed to evaluate HBV-specific CD4 T-cell responses and identify HBV-specific CD4 T-cell epitopes simultaneously using peripheral blood mononuclear cells samples from chronic HBV infection patients.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Currently, there are 3 main approaches to analyze antigen-specific T cells. The first approach is based on the interaction between the T-cell receptor and the peptide (epitope). Antigen-specific T cells could be directly stained with peptide-major histocompatibility complex (MHC) multimers. The advantage of this method is that it could obtain viable antigen-specific T cells, suitable for downstream transcriptomics/metabolomics analysis. A limitation of this method is that it could not provide information about the whole T-cell response to a specific antigen, as it requires validated epitope peptides while the number of identified epitopes for a specific antigen is lim....

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Written informed consent was obtained from each patient included in the study. The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the medical ethics committee of Southwest Hospital.

1. Design of the HBV-derived peptide matrix

  1. Download amino acid sequences of the HBV core antigen from NCBI databases (GenBank: AFY98989.1).
  2. Purchase HBV core antigen derived peptides (a panel of 35 15-mer peptides overlapping by 10 residues, purity > 90%, 4 mg/peptide) from a peptide synthesis service provider.
  3. Set up a square 6×6 peptide matrix with each....

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The frequency of cytokine secreting CD4 T cells are calculated as the sum of both single producers and double producers. As demonstrated in Figure 1, the frequency of TNF-α secreting CD4 T cells and the frequency of IFN-γ secreting CD4 T cells in background control (DMSO) are 0.154% and 0.013% respectively. The frequency of TNF-α secreting CD4 T cells and the frequency of IFN-γ secreting CD4 T cells specific for peptide pool Core11 are 0.206 and 0.017 respectively, so both TNF-α secreting CD.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The most critical steps in this protocol are listed as follows: 1) enough PBMCs of high viability to start PBMCs expansion; 2) appropriate environment for PBMCs expansion; and 3) complete removal of residual peptide pools in PBMCs culture before epitope identification.

All the analysis in this protocol depends on the robust proliferation of CD4 T cells. In general, the number of PBMCs after 10-day expansion will be 2-3 times of the initial number. The cell number and the viability of PBMCs are.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors have nothing to disclose.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This work was supported by National Natural Science Foundation of China (81930061), Chongqing Natural Science Foundation (cstc2019jcyj-bshX0039, cstc2019jcyj-zdxmX0004), and Chinese Key
Project Specialized for Infectious Diseases (2018ZX10723203).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Albumin Bovine V (BSA)BeyotimeST023
APC-conjugated Anti-human TNF-αeBioscience17-7349-82Keep protected from light
Benzonase NucleaseSigma-AldrichE1014Limit cell clumping
B lymphoblastoid cell lines (BLCLs)FRED HUTCHINSON CANCER RESEARCH CENTERIHW09126HLA-DRB1*0803 homozygote
B lymphoblastoid cell lines (BLCLs)FRED HUTCHINSON CANCER RESEARCH CENTERIHW09121HLA-DRB1*1202 homozygote
Cell Culture Flask (T75)Corning430641
Cell Culture Plate (96-well, flat bottom)Corning3599Flat bottom
Cell Culture Plate (96-well, round bottom)Corning3799Round bottom
Cell StrainerCorningCLS431751Pore size 70 μm, white, sterile
Centrifuge Tube (15 mL)KIRGENKG2611Sterile
Centrifuge Tube (50 mL)Corning430829Sterile
Centrifuge, RefrigeratedEppendorf5804R
Centrifuge, RefrigeratedThermoST16R
Centrifuge, RefrigeratedThermoLegend Micro 21R
Cytofix/Cytoperm Kit (Transcription Factor Buffer Set)BD Biosciences562574Prepare solution before use
Dimethyl Sulfoxide (DMSO)Sigma-AldrichD2650Keep at room temperature to prevent crystallization
Dulbecco’s Phosphate Buffered SalinePrepare ddH2O (1000 ml) containing NaCl (8000 mg), KCl (200 mg), KH2PO4 (200 mg), and Na2HPO4.7H2O (2160  mg). Adjust PH to 7.4. Sterilize through autoclave.
Ficoll-Paque PremiumGE Healthcare17-5442-03
Filter Tips (0.5-10)KirgenKG5131Sterile
Filter Tips (100-1000)KirgenKG5333Sterile
Filter Tips (1-200)KirgenKG5233Sterile
FITC-conjugated Anti-human CD4BioLegend300506Keep protected from light
Fixable Viability Dye eFluor780eBioscience65-0865-14Keep protected from light
GolgiStop Protein Transport Inhibitor (Containing Monensin)BD Biosciences554724Protein Transport Inhibitor
HaemocytometerBrand718620
HBV Core Antigen Derived PeptidesChinaPeptides
HEPESGibco15630080100 ml
Human Serum ABGemini Bio-Products100-51100 ml
IonomycinSigma-AldrichI0634
KClSangon BiotechA100395-0500
KH2PO4Sangon BiotechA100781-0500
LSRFortessa Flow CytometerBD
L-glutamineGibco25030081100 ml
Microcentrifuge Tube (1.5 mL)CorningMCT-150-CAutoclaved sterilization before using
Microplate ShakersScientific IndustriesMicroPlate Genie
Mitomycin CRoche10107409001
Na2HPO4.7H2OSangon BiotechA100348-0500
NaClSangon BiotechA100241-0500
PCR Tubes (0.2 mL)KirgenKG2331
PE/Cy7-conjugated Anti-human CD8BioLegend300914Keep protected from light
PE-conjugated Anti-human IFN-γeBioscience12-7319-42Keep protected from light
Penicillin StreptomycinGibco15140122100 ml
PerCP-Cy5.5-conjugated Anti-human CD3eBioscience45-0037-42Keep protected from light
Phorbol 12-myristate 13-acetate (PMA)Sigma-AldrichP1585
Recombinant Human IL-2PeproTech200-02
Recombinant Human IL-7PeproTech200-07
RPMI Medium 1640GibcoC11875500BT500 ml
Sodium pyruvate,100mMGibco15360070
Trypan Blue Stain (0.4%)Gibco15250-061
Ultra-LEAF Purified Anti-human HLA-DRBioLegend307648
Wizard Genomic DNA Purification KitPromegaA1125

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Desmond, C. P., Bartholomeusz, A., Gaudieri, S., Revill, P. A., Lewin, S. R. A systematic review of T-cell epitopes in hepatitis B virus: identification, genotypic variation and relevance to antiviral therapeutics. Antiviral Therapy. 13, 161-175 (2008).
  2. Mizukoshi, E., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

HBV Specific CD4 T CellsHLA DR Restricted EpitopesPeptide MatrixPeripheral Blood Mononuclear CellsFicoll Density GradientCytokine SecretionFlow CytometryIntracellular Cytokine StainingEpitope IdentificationChronic Hepatitis B

Related Articles